Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) CEO Saurabh Saha sold 55,000 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $16.53, for a total transaction of $909,150.00. Following the transaction, the chief executive officer now owns 721,924 shares in the company, […]

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report) major shareholder Braden Michael Leonard purchased 55,300 shares of the firm’s stock in a transaction on Tuesday, September 17th. The stock was acquired at an average price of $1.36 per share, for a total transaction of $75,208.00. Following the completion of the transaction, the insider now directly […]

Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) Director Andrew Regan sold 35,923 shares of the company’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $0.51, for a total transaction of $18,320.73. Following the completion of the sale, the director now directly owns 15,441,772 shares of […]

Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) Director Andrew Regan sold 1,389,820 shares of the company’s stock in a transaction dated Friday, July 12th. The shares were sold at an average price of $0.25, for a total transaction of $347,455.00. Following the transaction, the director now owns 12,941,319 shares in the company, valued at […]